Monoclonal antibodies in cancer therapy: 25 years of progress

J Clin Oncol. 2008 Apr 10;26(11):1774-7. doi: 10.1200/JCO.2007.15.7438.
No abstract available

Publication types

  • Historical Article
  • Comment

MeSH terms

  • Alemtuzumab
  • Animals
  • Antibodies, Monoclonal / history*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal / toxicity
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antibodies, Neoplasm / therapeutic use
  • Antineoplastic Agents / history
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents / toxicity
  • Bevacizumab
  • Disease Models, Animal
  • Forecasting
  • History, 20th Century
  • Humans
  • Immunotherapy / trends
  • Neoplasms / drug therapy*
  • Rituximab
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Bevacizumab
  • Alemtuzumab
  • Rituximab
  • Trastuzumab